Source comparison
CJC-1295 No DAC and Ipamorelin: Recovery Dosage Comparison
Single Injection Dose 100-300mcg subcutaneously 200-300mcg subcutaneously 200mcg CJC + 250mcg Ipa per injection 200/250mcg pairing maximises synergistic GH pulse amplitude without overshooting receptor saturation. Validated in multiple endocrinology studies We
This comparison does not assign a generated winner or score.
- Single Injection Dose
- 100-300mcg subcutaneously
- 200-300mcg subcutaneously
- 200mcg CJC + 250mcg Ipa per injection
- 200/250mcg pairing maximises synergistic GH pulse amplitude without overshooting receptor saturation. Validated in multiple endocrinology studies
- Weekly Frequency
- 3-5 injections per week
- 3-5 combined injections per week
- Daily dosing risks receptor downregulation; 3-5x weekly preserves pulsatile physiology
- Optimal Timing
- 30-60 min before sleep or post-training
- Same-time administration for pulse synchronization
- Before-bed timing aligns with natural nocturnal GH surge; post-training captures exercise-induced GH elevation
- Onset of Peak GH Levels
- 30-45 minutes post-injection
- 20-30 minutes post-injection
- Overlapping peaks at 30-40 minutes
- Simultaneous injection ensures multiplicative GH pulse rather than sequential smaller pulses
- Half-Life
- ~30 minutes (no DAC variant)
- ~2 hours
- N/A
- Short half-life of CJC no DAC requires Ipamorelin co-administration to extend effective GH elevation window
- Common Reconstitution Volume
- 2ml bacteriostatic water per 2mg vial
- Both reconstituted identically
- Standard 2ml reconstitution yields 100mcg per 0.1ml (10 units on insulin syringe). Simplifies dosing math